| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.001 |